CRMD stock news · CorMedix Inc.
Get alerts for CRMD
Follow CorMedix Inc. (CRMD) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for CRMDFree on the App Store and Google Play, or on the web.
CorMedix shares soar due to robust DefenCath sales performance.
Good for CRMDCorMedix's stock surged following the announcement of strong second-quarter results, with earnings and revenue exceeding expectations. The significant growth in DefenCath sales and positive guidance for future sales and EBITDA are likely to attract investor interest and confidence in the company's trajectory.
On Thursday, significant upward movement observed in major stocks including Accelerant Holdings, CorMedix, and Birkenstock.
Good for CRMDSurged 23.6% after reporting better-than-expected financial results.